These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38103086)

  • 1. Analysis of biomarkers in speculative CNS-enriched extracellular vesicles for parkinsonian disorders: a comprehensive systematic review and diagnostic meta-analysis.
    Taha HB; Bogoniewski A
    J Neurol; 2024 Apr; 271(4):1680-1706. PubMed ID: 38103086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular vesicles from bodily fluids for the accurate diagnosis of Parkinson's disease and related disorders: A systematic review and diagnostic meta-analysis.
    Taha HB; Bogoniewski A
    J Extracell Biol; 2023 Nov; 2(11):e121. PubMed ID: 38939363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of α-synuclein in CNS-originating extracellular vesicles for Parkinsonian disorders: A systematic review and meta-analysis.
    Taha HB; Ati SS
    CNS Neurosci Ther; 2023 Dec; 29(12):3741-3755. PubMed ID: 37416941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligomeric α-synuclein and tau aggregates in NDEVs differentiate Parkinson's disease from atypical parkinsonisms.
    Meloni M; Agliardi C; Guerini FR; Zanzottera M; Bolognesi E; Picciolini S; Marano M; Magliozzi A; Di Fonzo A; Arighi A; Fenoglio C; Franco G; Arienti F; Saibene FL; Navarro J; Clerici M
    Neurobiol Dis; 2023 Jan; 176():105947. PubMed ID: 36481435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies.
    Foulds PG; Yokota O; Thurston A; Davidson Y; Ahmed Z; Holton J; Thompson JC; Akiyama H; Arai T; Hasegawa M; Gerhard A; Allsop D; Mann DM
    Neurobiol Dis; 2012 Jan; 45(1):188-95. PubMed ID: 21856424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinson's Disease Diagnostic Observations (PADDO): study rationale and design of a prospective cohort study for early differentiation of parkinsonism.
    van Rumund A; Aerts MB; Esselink RAJ; Meijer FJA; Verbeek MM; Bloem BR
    BMC Neurol; 2018 May; 18(1):69. PubMed ID: 29764386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation patterns in the frontal lobe white matter of multiple system atrophy, Parkinson's disease, and progressive supranuclear palsy: a cross-comparative investigation.
    Murthy M; Fodder K; Miki Y; Rambarack N; De Pablo Fernandez E; Pihlstrøm L; Mill J; Warner TT; Lashley T; Bettencourt C
    Acta Neuropathol; 2024 Jul; 148(1):4. PubMed ID: 38995454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes.
    Magdalinou NK; Paterson RW; Schott JM; Fox NC; Mummery C; Blennow K; Bhatia K; Morris HR; Giunti P; Warner TT; de Silva R; Lees AJ; Zetterberg H
    J Neurol Neurosurg Psychiatry; 2015 Nov; 86(11):1240-7. PubMed ID: 25589779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders.
    Hall S; Öhrfelt A; Constantinescu R; Andreasson U; Surova Y; Bostrom F; Nilsson C; Håkan W; Decraemer H; Någga K; Minthon L; Londos E; Vanmechelen E; Holmberg B; Zetterberg H; Blennow K; Hansson O
    Arch Neurol; 2012 Nov; 69(11):1445-52. PubMed ID: 22925882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood neurofilament light chain in Parkinson disease and atypical parkinsonisms: A protocol for systematic review and meta-analysis.
    Wang H; Wang W; Shi H; Han L; Pan P
    Medicine (Baltimore); 2020 Oct; 99(40):e21871. PubMed ID: 33019386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presynaptic Striatal Dopaminergic Function in Atypical Parkinsonism: A Metaanalysis of Imaging Studies.
    Kaasinen V; Kankare T; Joutsa J; Vahlberg T
    J Nucl Med; 2019 Dec; 60(12):1757-1763. PubMed ID: 30979821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular vesicles contain filamentous alpha-synuclein and facilitate the propagation of Parkinson's pathology.
    Ishiguro Y; Tsunemi T; Shimada T; Yoroisaka A; Ueno SI; Takeshige-Amano H; Hatano T; Inoue Y; Saiki S; Hattori N
    Biochem Biophys Res Commun; 2024 Apr; 703():149620. PubMed ID: 38359614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular Vesicles for the Diagnosis of Parkinson's Disease: Systematic Review and Meta-Analysis.
    Xylaki M; Chopra A; Weber S; Bartl M; Outeiro TF; Mollenhauer B
    Mov Disord; 2023 Sep; 38(9):1585-1597. PubMed ID: 37449706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal Fluid Levels of 5-Hydroxyindoleacetic Acid in Parkinson's Disease and Atypical Parkinsonian Syndromes.
    Kaiserova M; Chudackova M; Prikrylova Vranova H; Mensikova K; Kastelikova A; Stejskal D; Kanovsky P
    Neurodegener Dis; 2021; 21(1-2):30-35. PubMed ID: 34695830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of autopsy-confirmed multiple system atrophy in the Mayo Clinic Florida brain bank.
    Koga S; Cheshire WP; Tipton PW; Driver-Dunckley ED; Wszolek ZK; Uitti RJ; Graff-Radford NR; van Gerpen JA; Dickson DW
    Parkinsonism Relat Disord; 2021 Aug; 89():155-161. PubMed ID: 34303202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy.
    Boeve BF; Silber MH; Ferman TJ; Lucas JA; Parisi JE
    Mov Disord; 2001 Jul; 16(4):622-30. PubMed ID: 11481685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-motor symptoms in multiple system atrophy: A comparative study with Parkinson's disease and progressive supranuclear palsy.
    Hu WZ; Cao LX; Yin JH; Zhao XS; Piao YS; Gu WH; Ma JH; Wan ZR; Huang Y
    Front Neurol; 2022; 13():1081219. PubMed ID: 36756345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of α-Synuclein in L1CAM-Immunocaptured Exosomes as a Biomarker for the Stratification of Parkinsonian Syndromes.
    Jiang C; Hopfner F; Berg D; Hu MT; Pilotto A; Borroni B; Davis JJ; Tofaris GK
    Mov Disord; 2021 Nov; 36(11):2663-2669. PubMed ID: 33826157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine transporter SPECT imaging in Parkinson's disease and atypical Parkinsonism: a study of 137 patients.
    Constantinides VC; Souvatzoglou M; Paraskevas GP; Chalioti M; Stefanis L; Kapaki E
    Neurol Sci; 2023 May; 44(5):1613-1623. PubMed ID: 36658411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid NFL in the differential diagnosis of parkinsonian disorders: A meta-analysis.
    Ge F; Ding J; Liu Y; Lin H; Chang T
    Neurosci Lett; 2018 Oct; 685():35-41. PubMed ID: 30036569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.